Onco-Inmunología Aplicada y Traslacional
O-I Traslacional
Hospital Universitario 12 de Octubre
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (5)
2019
-
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132
-
Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Actas Dermo-Sifiliograficas, Vol. 110, Núm. 6, pp. 448-459
-
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 556-571
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97